Navidea Biopharmaceuticals PE Ratio 2006-2019 | NAVB
Current and historical p/e ratio for Navidea Biopharmaceuticals (NAVB) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Navidea Biopharmaceuticals PE ratio as of December 09, 2019 is 0.00.
| Navidea Biopharmaceuticals PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2019-12-09 | 1.00 | 0.00 | |
| 2019-09-30 | 0.69 | $-1.05 | 0.00 |
| 2019-06-30 | 0.63 | $-1.28 | 0.00 |
| 2019-03-31 | 0.14 | $-1.44 | 0.00 |
| 2018-12-31 | 0.10 | $-2.00 | 0.00 |
| 2018-09-30 | 0.23 | $-2.20 | 0.00 |
| 2018-06-30 | 0.23 | $-2.00 | 0.00 |
| 2018-03-31 | 0.36 | $-2.20 | 0.00 |
| 2017-12-31 | 0.36 | $9.00 | 0.04 |
| 2017-09-30 | 0.42 | $9.20 | 0.05 |
| 2017-06-30 | 0.51 | $9.40 | 0.05 |
| 2017-03-31 | 0.58 | $9.20 | 0.06 |
| 2016-12-31 | 0.64 | $-1.60 | 0.00 |
| 2016-09-30 | 0.92 | $-1.60 | 0.00 |
| 2016-06-30 | 0.53 | $-2.60 | 0.00 |
| 2016-03-31 | 0.94 | $-3.00 | 0.00 |
| 2015-12-31 | 1.33 | $-3.60 | 0.00 |
| 2015-09-30 | 2.28 | $-4.20 | 0.00 |
| 2015-06-30 | 1.61 | $-4.20 | 0.00 |
| 2015-03-31 | 1.59 | $-4.40 | 0.00 |
| 2014-12-31 | 1.89 | $-5.00 | 0.00 |
| 2014-09-30 | 1.32 | $-6.00 | 0.00 |
| 2014-06-30 | 1.48 | $-6.80 | 0.00 |
| 2014-03-31 | 1.85 | $-7.20 | 0.00 |
| 2013-12-31 | 2.07 | $-6.80 | 0.00 |
| 2013-09-30 | 2.65 | $-6.20 | 0.00 |
| 2013-06-30 | 2.67 | $-6.20 | 0.00 |
| 2013-03-31 | 2.71 | $-5.60 | 0.00 |
| 2012-12-31 | 2.83 | $-5.80 | 0.00 |
| 2012-09-30 | 2.75 | $-6.00 | 0.00 |
| 2012-06-30 | 3.72 | $0.00 | 0.00 |
| 2012-03-31 | 3.28 | $0.80 | 4.10 |
| 2011-12-31 | 2.62 | $1.20 | 2.18 |
| 2011-09-30 | 2.96 | $2.20 | 1.35 |
| 2011-06-30 | 3.32 | $-2.60 | 0.00 |
| 2011-03-31 | 3.95 | $-15.00 | 0.00 |
| 2010-12-31 | 2.06 | $-14.60 | 0.00 |
| 2010-09-30 | 1.88 | $-14.00 | 0.00 |
| 2010-06-30 | 1.80 | $-20.20 | 0.00 |
| 2010-03-31 | 1.64 | $-11.60 | 0.00 |
| 2009-12-31 | 1.22 | $-10.80 | 0.00 |
| 2009-09-30 | 1.40 | $-11.20 | 0.00 |
| 2009-06-30 | 0.95 | $-5.00 | 0.00 |
| 2009-03-31 | 0.54 | $-1.00 | 0.00 |
| 2008-12-31 | 0.57 | $-1.60 | 0.00 |
| 2008-09-30 | 0.57 | $-1.80 | 0.00 |
| 2008-06-30 | 0.68 | $-1.40 | 0.00 |
| 2008-03-31 | 0.35 | $-1.60 | 0.00 |
| 2007-12-31 | 0.29 | $-1.60 | 0.00 |
| 2007-09-30 | 0.31 | $-1.40 | 0.00 |
| 2007-06-30 | 0.27 | $-1.80 | 0.00 |
| 2007-03-31 | 0.24 | $-1.60 | 0.00 |
| 2006-12-31 | 0.24 | $-1.60 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.018B | $0.001B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $128.365B | 26.59 |
| Intuitive Surgical (ISRG) | United States | $67.676B | 53.19 |
| Edwards Lifesciences (EW) | United States | $49.844B | 45.26 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $21.604B | 14.62 |
| IDEXX Laboratories (IDXX) | United States | $21.563B | 52.15 |
| Olympus (OCPNY) | Japan | $20.609B | 0.00 |
| DexCom (DXCM) | United States | $20.572B | 184.23 |
| Teleflex (TFX) | United States | $17.037B | 34.59 |
| Sysmex ADR (SSMXY) | Japan | $14.750B | 39.70 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.424B | 0.00 |
| Hologic (HOLX) | United States | $14.142B | 21.61 |
| STERIS (STE) | Ireland | $13.082B | 28.90 |
| Varian Medical Systems (VAR) | United States | $12.590B | 29.85 |
| ABIOMED (ABMD) | United States | $8.544B | 46.49 |
| Masimo (MASI) | United States | $8.293B | 49.52 |
| Penumbra (PEN) | United States | $5.856B | 190.60 |
| Globus Medical (GMED) | United States | $5.684B | 35.08 |
| SARTORIUS AG (SARTF) | Germany | $5.614B | 49.28 |
| Integra LifeSciences Holdings (IART) | United States | $5.345B | 22.97 |
| Elekta AB (EKTAY) | Sweden | $4.667B | 35.93 |
| LivaNova (LIVN) | United Kingdom | $4.033B | 29.03 |
| Wright Medical Group (WMGI) | Netherlands | $3.750B | 227.31 |
| Tandem Diabetes Care (TNDM) | United States | $3.618B | 0.00 |
| Nevro (NVRO) | United States | $3.508B | 0.00 |
| Cantel Medical (CMD) | United States | $3.309B | 32.79 |
| Integer Holdings (ITGR) | United States | $2.589B | 17.73 |
| Nihon Kohden (NHNKY) | Japan | $2.376B | 23.90 |
| Glaukos (GKOS) | United States | $2.182B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.596B | 31.42 |
| Inogen (INGN) | United States | $1.590B | 50.19 |
| Veracyte (VCYT) | United States | $1.425B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.217B | 139.09 |
| Silk Road Medical (SILK) | United States | $1.086B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $1.083B | 40.15 |
| Natus Medical (NTUS) | United States | $1.076B | 25.86 |
| OPKO Health (OPK) | United States | $1.072B | 0.00 |
| Luminex (LMNX) | United States | $0.942B | 0.00 |
| CryoLife (CRY) | United States | $0.936B | 96.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.882B | 29.31 |
| Accelerate Diagnostics (AXDX) | United States | $0.868B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.765B | 0.00 |
| Intersect ENT (XENT) | United States | $0.665B | 0.00 |
| AxoGen (AXGN) | United States | $0.658B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.601B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.586B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.580B | 20.82 |
| Si-Bone (SIBN) | United States | $0.458B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.456B | 13.80 |
| Sientra (SIEN) | United States | $0.412B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.412B | 0.00 |
| ViewRay (VRAY) | United States | $0.400B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.328B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.282B | 39.18 |
| IRadimed (IRMD) | United States | $0.263B | 36.90 |
| Accuray (ARAY) | United States | $0.256B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.249B | 0.00 |
| Fluidigm (FLDM) | United States | $0.177B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.151B | 40.80 |
| EDAP TMS S.A (EDAP) | France | $0.140B | 37.15 |
| Spectral Diagnostics (EDTXF) | Canada | $0.110B | 0.00 |
| ConforMIS (CFMS) | United States | $0.107B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.102B | 0.00 |
| Neuronetics (STIM) | United States | $0.086B | 0.00 |
| Restoration Robotics (VERO) | Canada | $0.082B | 0.00 |
| Vermillion (VRML) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.064B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.058B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.057B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.047B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.040B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.036B | 0.00 |
| Neovasc (NVCN) | Canada | $0.022B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.019B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.018B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.016B | 0.00 |
| Avinger (AVGR) | United States | $0.015B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.014B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.014B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.009B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.007B | 0.00 |
| Dynatronics (DYNT) | United States | $0.006B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.003B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.001B | 0.00 |
